- Home
- XTKG vs PRPH Comparison
XTKG vs PRPH Comparison
Compare XTKG & PRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XTKG
- PRPH
- Stock Information
- Founded
- XTKG 1997
- PRPH 1989
- Country
- XTKG Singapore
- PRPH United States
- Employees
- XTKG N/A
- PRPH N/A
- Industry
- XTKG
- PRPH Biotechnology: Pharmaceutical Preparations
- Sector
- XTKG
- PRPH Health Care
- Exchange
- XTKG NYSE
- PRPH Nasdaq
- Market Cap
- XTKG 16.3M
- PRPH 15.2M
- IPO Year
- XTKG 2019
- PRPH 1997
- Fundamental
- Price
- XTKG $1.55
- PRPH $0.40
- Analyst Decision
- XTKG
- PRPH
- Analyst Count
- XTKG 0
- PRPH 0
- Target Price
- XTKG N/A
- PRPH N/A
- AVG Volume (30 Days)
- XTKG 106.9K
- PRPH 4.1M
- Earning Date
- XTKG 07-07-2025
- PRPH 08-13-2025
- Dividend Yield
- XTKG N/A
- PRPH N/A
- EPS Growth
- XTKG N/A
- PRPH N/A
- EPS
- XTKG N/A
- PRPH N/A
- Revenue
- XTKG $11,611,442.00
- PRPH $5,845,000.00
- Revenue This Year
- XTKG N/A
- PRPH $221.82
- Revenue Next Year
- XTKG N/A
- PRPH N/A
- P/E Ratio
- XTKG N/A
- PRPH N/A
- Revenue Growth
- XTKG N/A
- PRPH N/A
- 52 Week Low
- XTKG $0.53
- PRPH $0.22
- 52 Week High
- XTKG $11.60
- PRPH $4.33
- Technical
- Relative Strength Index (RSI)
- XTKG 49.51
- PRPH 53.41
- Support Level
- XTKG $1.36
- PRPH $0.32
- Resistance Level
- XTKG $2.24
- PRPH $0.37
- Average True Range (ATR)
- XTKG 0.23
- PRPH 0.03
- MACD
- XTKG -0.03
- PRPH -0.00
- Stochastic Oscillator
- XTKG 22.22
- PRPH 50.00
About XTKG X3 HOLDINGS CO LTD
X3 Holdings Co Ltd is company which is responsible for globally providing of Technology Solutions and Services across Diverse Industries. It generates revenue from service lines: Application development services; Consulting and technical support services; Subscription services; Trading; and Others, of which maximum revenue is derived from Application development services. Geographically, all of the company's revenue is derived from PRC.
About PRPH ProPhase Labs Inc. (DE)
ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.